Company Overview - BenQ BM Holding Cayman Corp., referred to as "BenQ Hospital Group," is a private for-profit comprehensive hospital group in mainland China, leveraging operational management experience from Taiwan [1] - The group currently operates two comprehensive hospitals: Nanjing BenQ Hospital, a tertiary A hospital and the first private hospital in Nanjing to receive this rating, and Suzhou BenQ Hospital, also a tertiary hospital certified by the Joint Commission International (JCI) [1] Listing Details - The company has submitted a hearing document for a potential listing on the Hong Kong Stock Exchange, with CICC and Citigroup as joint sponsors [1] - The funds raised from the IPO will be allocated for various purposes, including expansion and upgrading of existing hospitals, potential investments and acquisitions, upgrading the "smart hospital" system, and general corporate purposes [3] Services and Operations - Nanjing BenQ Hospital is recognized as a national chest pain center and a demonstration base for health management, providing integrated medical, teaching, research, and operational services [1] - Suzhou BenQ Hospital has established differentiated advantages in departments such as obstetrics and pediatrics, and offers palliative care services [1] - The group aims to enhance operational efficiency and medical service quality through refined management and adaptability to the Diagnosis-Related Group (DRG) payment system [1]

Group 1 - The core business of Ailong Technology focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for medical institutions [2] - As of August 8, 2025, the number of shareholders in Ailong Technology increased by 3.45% to 4,711, while the average circulating shares per person decreased by 3.33% to 16,387 shares [2] - For the first half of 2025, Ailong Technology reported a revenue of 131 million yuan, a year-on-year decrease of 8.11%, and a net profit attributable to shareholders of -8.39 million yuan, an increase of 55.47% year-on-year [2] Group 2 - Ailong Technology has distributed a total of 111 million yuan in dividends since its A-share listing, with 49.05 million yuan distributed over the past three years [3] - As of June 30, 2025, the sixth largest circulating shareholder of Ailong Technology is Dazheng Zhongzheng 360 Internet+ Index A, holding 828,300 shares as a new shareholder [3] Group 3 - On August 26, Ailong Technology's stock price increased by 0.40%, with a trading volume of 41.91 million yuan [1] - The financing buy-in amount for Ailong Technology on August 26 was 4.86 million yuan, with a net financing buy-in of 643,800 yuan, while the total financing and securities balance reached 68.61 million yuan, accounting for 3.92% of the circulating market value [1] - The securities lending data for Ailong Technology on August 26 showed no shares were lent or repaid, indicating a high level of securities lending balance at 0.00 shares, which is above the 90th percentile over the past year [1]